Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9372)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 15, 2016 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee JM, Lee HS, Hyun JJ, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, Chun HJ, Um SH, Kim CD. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. World J Gastrointest Oncol 2016; 8(7): 555-562 [PMID: 27559435 DOI: 10.4251/wjgo.v8.i7.555] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i7/555.htm |
| Number | Citing Articles |
| 1 |
Yavuz Karabağ, Metin Çağdaş, Ibrahim Rencuzogullari, Süleyman Karakoyun, İnanç Artaç, Doğan İliş, Eray Atalay, Mahmut Yesin, Mustafa Ozan Gürsoy, Ibrahim Halil Tanboğa. Relationship between C‐reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. Journal of Clinical Laboratory Analysis 2018; 32(7) doi: 10.1002/jcla.22457
|
| 2 |
Chiou Yi Ho, Zuriati Ibrahim, Zalina Abu Zaid, Zulfitri 'Azuan Mat Daud, Nor Baizura Md Yusop. Clinical malnutrition predictive model among gynecologic cancer patients prior to elective operation: A cross-sectional study. Clinical Nutrition 2021; 40(6): 4373 doi: 10.1016/j.clnu.2021.01.008
|
| 3 |
Baoshan Di, Bei Pan, Long Ge, Jichun Ma, Yiting Wu, Tiankang Guo. Targeted agents for patients with advanced/metastatic pancreatic cancer. Medicine 2018; 97(13): e0115 doi: 10.1097/MD.0000000000010115
|
| 4 |
Wendi Li, Lianyuan Tao, Meng Lu, Dianrong Xiu. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers. Medicine 2018; 97(8): e9616 doi: 10.1097/MD.0000000000009616
|
| 5 |
Riki Ohno, Ryuichi Kawamoto, Mami Kanamoto, Jota Watanabe, Masahiko Fujii, Hiromi Ohtani, Masamitsu Harada, Teru Kumagi, Hideki Kawasaki. Neutrophil to Lymphocyte Ratio is a Predictive Factor of Malignant Potential for Intraductal Papillary Mucinous Neoplasms of the pancreas. Biomarker Insights 2019; 14: 117727191985150 doi: 10.1177/1177271919851505
|
| 6 |
Elisabeth S. Gruber, Gerd Jomrich, Alexandra Kaider, Michael Gnant, Klaus Sahora, Martin Schindl. The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. Annals of Surgical Oncology 2020; 27(6): 2017 doi: 10.1245/s10434-019-08161-6
|
| 7 |
Byung Min Lee, Seung Yeun Chung, Jee Suk Chang, Kyong Joo Lee, Jinsil Seong. The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy. Gut and Liver 2018; 12(3): 342 doi: 10.5009/gnl17216
|
| 8 |
Ye Zang, Yu Fan, Zhenjun Gao. Pretreatment C-reactive protein/albumin ratio for predicting overall survival in pancreatic cancer. Medicine 2020; 99(23): e20595 doi: 10.1097/MD.0000000000020595
|
| 9 |
Shinichi Ikuta, Tsukasa Aihara, Naoki Yamanaka. Preoperative C‐reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma. Asia-Pacific Journal of Clinical Oncology 2019; 15(5) doi: 10.1111/ajco.13123
|
| 10 |
Arturs Silovs, Ilze Strumfa, Reinis Riekstins, Zane Simtniece, Andrejs Vanags, Janis Gardovskis. Advances in Pancreatic Cancer. 2018; doi: 10.5772/intechopen.78954
|
| 11 |
Qinfen Xie, Lidong Wang, Shusen Zheng. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis. Dose-Response 2020; 18(2): 155932582093129 doi: 10.1177/1559325820931290
|
| 12 |
Yan-Jun Fu, Ke-Zhi Li, Ji-Hong Bai, Zhi-Qing Liang. C-reactive protein/albumin ratio is a prognostic indicator in Asians with pancreatic cancers. Medicine 2019; 98(48): e18219 doi: 10.1097/MD.0000000000018219
|
| 13 |
Lin Zhou, Jing Wang, Xin-xue Zhang, Shao-cheng Lyu, Li-chao Pan, Guo-sheng Du, Ren Lang, Qiang He. Prognostic Value of Preoperative NLR and Vascular Reconstructive Technology in Patients With Pancreatic Cancer of Portal System Invasion: A Real World Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.682928
|
| 14 |
Yoshikane Yamauchi, Seyer Safi, Thomas Muley, Arne Warth, Felix J.F. Herth, Hendrik Dienemann, Hans Hoffmann, Martin E. Eichhorn. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients. Lung Cancer 2017; 114: 62 doi: 10.1016/j.lungcan.2017.11.002
|
| 15 |
Zheng-Shui Xu, Fa-Peng Zhang, Yin Zhang, Yong-Peng Ou-Yang, Xiao-Wen Yu, Wen-Long Wang, Wen-Ji Xu, Zhi-Qiang Luo. Prognostic role of the pre-treatment platelet-lymphocyte ratio in pancreatic cancer: a meta-analysis. Oncotarget 2017; 8(58): 99003 doi: 10.18632/oncotarget.20871
|
| 16 |
Imad Radi, Ramy Samaha, Joanna El Hajj, Hady Samaha, Hampig Raphael Kourie. Perioperative chemotherapy with modified FOLFIRINOX for nonmetastatic pancreatic cancer: a new standard of care?. Future Oncology 2021; 17(3): 229 doi: 10.2217/fon-2020-0836
|
| 17 |
Anna M. Nurmi, Harri K. Mustonen, Ulf-Håkan Stenman, Hanna E. Seppänen, Caj H. Haglund. Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80778-0
|
| 18 |
Yongping Zhou, Qian Wei, Junsheng Fan, Sijin Cheng, Wenzhou Ding, Zhiyuan Hua. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients. Clinica Chimica Acta 2018; 479: 181 doi: 10.1016/j.cca.2018.01.024
|
| 19 |
Caitlin A. McIntyre, Alessandra Pulvirenti, Sharon A. Lawrence, Kenneth Seier, Mithat Gonen, Vinod P. Balachandran, T. Peter Kingham, Michael I. D'Angelica, Jeffrey A. Drebin, William R. Jarnagin, Peter J. Allen. Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. Pancreas 2019; 48(6): 832 doi: 10.1097/MPA.0000000000001342
|
| 20 |
Shahin Hajibandeh, Shahab Hajibandeh, Saleh Romman, Alessandro Parente, Richard W. Laing, Thomas Satyadas, Daren Subar, Somaiah Aroori, Anand Bhatt, Damien Durkin, Tejinderjit S. Athwal, Keith J. Roberts. Preoperative C-Reactive Protein-to-Albumin Ratio and Its Ability to Predict Outcomes of Pancreatic Cancer Resection: A Systematic Review. Biomedicines 2023; 11(7): 1983 doi: 10.3390/biomedicines11071983
|
| 21 |
Ionut Negoi, Mircea Beuran, Sorin Hostiuc, Alaa El-Hussuna, Enrique de-Madaria. Platelet-to-lymphocyte ratio and CA19-9 are simple and informative prognostic factors in patients with resected pancreatic cancer. Hepatobiliary & Pancreatic Diseases International 2019; 18(3): 203 doi: 10.1016/j.hbpd.2019.03.011
|
| 22 |
Feng Yang, Chen Jin, De-Liang Fu, Andrew L Warshaw. Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges. World Journal of Gastroenterology 2019; 25(23): 2839-2845 doi: 10.3748/wjg.v25.i23.2839
|
| 23 |
Jiayuan Wu, Wenkai Tan, Lin Chen, Zhe Huang, Shao Mai. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis. Oncotarget 2018; 9(17): 13934 doi: 10.18632/oncotarget.24172
|
| 24 |
Akhil Chawla, Tiffany L. Huang, Andrew M. Ibrahim, Jeffrey M. Hardacre, Christopher Siegel, John B. Ammori. Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer. HPB 2018; 20(5): 398 doi: 10.1016/j.hpb.2017.10.011
|
| 25 |
Jing Zhang, Chenbo Zhang, Qingxian Li, Jiawen Zhang, Xiaoli Gu, Weiwei Zhao, Menglei Chen, Minghui Liu, Zhe Zhang, Xinghe Liao, Wenwu Cheng. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care. Journal of Palliative Medicine 2019; 22(12): 1536 doi: 10.1089/jpm.2019.0102
|
| 26 |
Dongwook Oh, Jung-Soo Pyo, Byoung Kwan Son. Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/9745601
|
| 27 |
Mohadeseh Fathi, Hamid Asadzadeh Aghdaie, Soudeh Ghafouri-Fard, Roshanak Shams. Evaluation of potential of miR-8073 and miR-642 as diagnostic markers in pancreatic cancer. Molecular Biology Reports 2022; 49(7): 6475 doi: 10.1007/s11033-022-07476-0
|
| 28 |
Feng Yang, Yun Bao, Zhongwen Zhou, Chen Jin, Deliang Fu. Preoperative neutrophil‐to‐lymphocyte ratio predicts malignancy and recurrence‐free survival of solid pseudopapillary tumor of the pancreas. Journal of Surgical Oncology 2019; 120(2): 241 doi: 10.1002/jso.25484
|